Fujian Cosunter Pharmaceutical: Written commitment from independent director Lu Fengmin regarding attendance at the most recent independent director training and acquisition of the independent director qualification certificate.
Fujian Cosunter Pharmaceutical: Announcement Regarding the Board of Directors' Election.
Fujian Cosunter Pharmaceutical: Statement and Commitment of Independent Director Nominee (Nominee: Lu Fengmin)
Fujian Cosunter Pharmaceutical: Announcement Regarding the Resolutions of the 28th Meeting of the Fourth Supervisory Committee.
Fujian Cosunter Pharmaceutical: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.
Fujian Cosunter Pharmaceutical: Statement and Commitment of Independent Director Candidate (Wu Hongjun)
Fujian Cosunter Pharmaceutical: Statement and Commitment of Independent Director Candidate (Lu Fengmin)
Fujian Cosunter Pharmaceutical: Statement and Commitment of Independent Director Nominee (Nominee: Wu Feimei)
Fujian Cosunter Pharmaceutical: Statement and Commitment of Independent Director Nominee (Nominee: Wu Hongjun)
Fujian Cosunter Pharmaceutical: Statement and Commitment of Independent Director Candidate (Wu Feimei)
Fujian Cosunter Pharmaceutical: Announcement Regarding the Resolutions of the 31st Meeting of the Fourth Board of Directors.
Fujian Cosunter Pharmaceutical: Announcement on the Election of the Supervisory Board
Fujian Cosunter Pharmaceutical: Notice on Ursodeoxycholic Acid Capsules Obtaining Drug Production Registration Approval
Fujian Cosunter Pharmaceutical: Societe Generale Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Fujian Guangshengtang Pharmaceutical Co., Ltd.
Fujian Cosunter Pharmaceutical: Announcement on the resolution of the 2023 Annual General Meeting of Shareholders
Fujian Cosunter Pharmaceutical: Legal Opinion of Guohao Lawyers (Shanghai) Firm on the 2023 Annual General Meeting of Shareholders of Fujian Guangshengtang Pharmaceutical Co., Ltd.
Fujian Cosunter Pharmaceutical: Societe Generale Securities Co., Ltd.'s summary report on the sponsorship of Fujian Guangshengtang Pharmaceutical Co., Ltd.
Fujian Cosunter Pharmaceutical: Announcement on the pledge of part of the company's actual controller's shares
Koseido: 300436 Koseido Investor Relations Management Information 20240424
Guangshengtang: Announcement on amending the “Articles of Association”
No Data